ACE and diabetic kidney disease: Inhibitors of RAAS, such as angiotensin-converting enzyme inhibitors (ACEIs) and Ang II receptor blockers (ARBs), drastically reduced the course of DKD [17,23,50,51,52], having success rates from 30% to 60% by lowering proteinuria and maintaining renal function [53].